CCM
KITE

Cadence Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Cadence Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-30,830
Closed -$1.78M – 701
2015
Q1 		$1.78M Buy
+30,830
New +$2.07M 0.11% 254

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cadence Capital Management's KITE Position: Q2 2015 in Review

Cadence Capital Management sold out of Kite Pharma, Inc. (KITE) in Q2 2015, closing a stake of 30,830 shares — an estimated $1.78M sold.

Cadence Capital Management first reported a position in KITE in Q1 2015 and held it in 1 quarter. The position peaked at $1.78M in Q1 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

  • Cadence Capital Management reported no remaining Kite Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • Cadence Capital Management sold 30,830 Kite Pharma, Inc. shares in Q2 2015, an estimated $1.78M.
  • Cadence Capital Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 1 quarter.
  • Cadence Capital Management's Kite Pharma, Inc. position peaked at $1.78M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.